Coca-Cola Europacific Partners PLC
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CCEP research report →
Range $106 – $119
Price Chart
About the company
Coca-Cola Europacific Partners PLC (CCEP), along with its affiliated entities, focuses on the creation, distribution, and sale of a wide array of non-alcoholic, ready-to-consume beverages. Their diverse product portfolio includes sparkling drinks, still and enhanced water products, isotonic options, teas, coffees, juices, as well as a variety of energy drinks and mixers. These offerings are marketed under numerous prominent brands, notably flagship names such as Coca-Cola, Fanta, Sprite, and Monster Energy, among a host of others.
- CEO
- Damian Paul Gammell
- IPO
- 1986
- Employees
- 39,000
- HQ
- Uxbridge, GL, GB
AI snapshot
Six angles, distilled from the data.
The stock is in a constructive medium-term recovery, trading above its 200-day average of 98.57 and below its 50-day average of 106.10. It remains well under the 52-week high of 113.67, so the setup is a rebound within a broader range rather than a full breakout.
Street sentiment stays constructive, with a Buy consensus and a $111.75 average target versus the last close near 102.29. Recent calls have been mixed but still supportive: UBS cut to Neutral, while Barclays, Wells Fargo, and Bernstein kept targets in the $106-$119 range, signaling cautious upside.
The earnings backdrop is solid but not flawless. EPS has grown 9% year over year and revenue 4.4%, while the next-year EPS estimate sits slightly below TTM at 4.91 versus 5.05, suggesting expectations are steady rather than accelerating. Shareholders should watch margin durability and cash conversion.
No notable insider buying or selling in recent quarters. With no reported transactions, there is no clear discretionary signal from management activity.
Profitability is healthy, with a 35.6% gross margin, 13.4% operating margin, and 9.35% net margin. Returns are respectable at 23.54% ROE and 5.64% ROA, while free cash flow of $3.70 billion and an 8.18% FCF yield support the equity story.
CCEP looks like a steadier, lower-volatility beverage name, with beta at 0.475 and a large global bottling footprint. At 20.62x earnings, it trades at a reasonable consumer staples multiple, with valuation anchored more to cash flow and resilience than rapid growth.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $44.79B
- P/E
- 20.22
- Fwd P/E
- 22.96
- PEG
- 0.61
- P/S
- 1.86
- P/B
- 4.84
- EV/EBITDA
- 14.03
- Div Yield
- 2.25%
- Gross Margin
- 35.56%
- Op Margin
- 13.52%
- Net Margin
- 9.35%
- ROE
- 24.78%
- ROIC
- 8.95%
Latest fiscal year · YoY change
- Revenue
- $20.90B+2.3%
- Gross Profit
- $7.44B+2.1%
- Op Income
- $2.79B
- Net Income
- $1.94B+37.0%
- EPS
- $4.09+32.8%
- OCF Growth
- -3.5%
- FCF Growth
- -3.0%
- 52W High
- $113.67
- 52W Low
- $84.66
- 50D MA
- $105.85
- 200D MA
- $98.75
- Beta
- 0.48
- RSI (14)
- 43
- Avg Volume
- 1.80M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Coca-Cola Europacific Partners said first-half 2026 performance was strong across sales, profits and cash flow, and reiterated full-year guidance despite expecting a softer second half because of fewer trading days and higher costs later in the year.· August 4, 2026
- Revenue rose 6.1% to EUR 10.7 billion, with volumes up 5.6% and operating profit up 8.1% to EUR 1.5 billion.
- Diluted EPS increased 10.6% to EUR 2.20; operating margin improved to 13.8% and free cash flow was EUR 435 million.
- Management said June was the biggest volume month ever, share was up 20 bps, and Europe led share gains while Southeast Asia continued to build.
- The company reaffirmed all full-year 2026 guidance, including at least EUR 1.7 billion of comparable free cash flow and said it remains on track despite 6 fewer trading days in 2H.
- Growth was driven by innovation, zero sugar, energy, sports/hydration, cooler expansion, and major FIFA-related activation; management sees these as supportive into 2027.
CCEP reported first-half revenue of EUR 10.7 billion, up 6.1%; volumes rose 5.6%, or 2.2% on a days-adjusted basis; revenue per case increased 0.4%; cost of sales per unit case increased 0.6%; OpEx as a percentage of revenue improved to 21.4%; operating profit was EUR 1.5 billion, up 8.1%; operating margin was 13.8%, up around 30 bps; diluted EPS was EUR 2.20, up 10.6%; and free cash flow was EUR 435 million, slightly ahead of last year. Management also said around EUR 600 million of the full-year EUR 1 billion share buyback had been completed. For guidance, the company reaffirmed full-year 2026 guidance, including comparable free cash flow of at least EUR 1.7 billion, and said the full-year outlook already reflects 6 fewer trading days in the second half and higher commodity costs that will mostly fall in 2H.
Damian Gammell framed the quarter as evidence that CCEP’s strategy is working, emphasizing broad-based growth, share gains, disciplined costs and strong cash generation. He highlighted execution in fast-growing categories like zero sugar, energy, sports and hydration, plus innovation, cooler rollout, customer wins and FIFA activation as key drivers. His tone was confident and forward-looking, repeatedly saying the company is well positioned to continue compounding growth and to benefit in 2027 from current innovation and strategic investments.
Ed Walker backed up the operating update with specific financial detail: cost of sales per unit case was up 0.6% versus a full-year guide of 1.5%, OpEx fell to 21.4% of revenue, operating margin reached 13.8%, and free cash flow was EUR 435 million after investment in coolers, a Powerade warmfill line in Australia, can fillers in Sweden and the Manila greenfield site. He said the company remains on track for at least EUR 1.7 billion of comparable free cash flow for the year and reiterated that around EUR 600 million of the EUR 1 billion buyback is already complete. On hedging, he said CCEP is aiming to be 80% covered for the coming year and has not delayed hedging despite Middle East-related volatility.
Analysts focused on whether pricing can keep supporting growth, whether the second half guidance is conservative, and how much of the strong Q2 volume was pulled forward by FIFA or weather. Management said there was “zero pull forward” into Q3, that Q2 momentum continued into July, and that the softer H2 outlook mainly reflects timing, fewer selling days, and the fact that some commodity and Middle East-related costs land later in the year. Questions also centered on Europe revenue per case, Indonesia’s turnaround, coolers, and AI; management said Europe’s Q2 revenue per case was 1.4%, mix remained healthy, Indonesia’s sparkling performance and route-to-market changes are encouraging, cooler returns are typically within a couple of years, and KIRA AI is already speeding up promo, pack and customer decisions.
The bullish case is that CCEP is delivering growth across volume, price/mix, profit and cash all at once, while still investing heavily behind future growth. Management pointed to strong momentum in zero sugar, energy, sports and Southeast Asia, plus customer wins, cooler expansion and AI tools that could improve execution further. They also sounded confident that many of the current wins will carry into 2027.
The main risks flagged were a tougher second half with 6 fewer trading days, higher costs landing later in the year, and continued volatility in commodity and Middle East-related inputs. Management also acknowledged some softness in Coke Classic volume versus zero-sugar alternatives, pressure on tea in Indonesia, and ongoing affordability sensitivity in some markets. Several analysts pressed on whether the company’s upbeat commentary implies guidance is conservative, suggesting some uncertainty around how much further growth can accelerate from here.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 44.6%
- Shares Outstanding
- 443.22M
- Float Shares
- 197.52M
of shares held by institutions
586 13F filers
Congressional trading
Senate and House stock disclosures for CCEP, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Alan ArmstrongSenate | Buy | Mar 30, 26 | Filing → |
| Val HoyleHouse · OR04 | Buy | Oct 29, 24 | Filing → |
| Val HoyleHouse · OR04 | Sell | Jun 26, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Feb 10, 23 | Filing → |
| William Francis HagertySenate · TN | Sell | Dec 29, 21 | Filing → |
| Katherine M. ClarkHouse · MA05 | Sell | Sep 16, 21 | Filing → |
| Chris JacobsHouse · NY27 | Sell | Jan 4, 21 | Filing → |
| Katherine M. ClarkHouse · MA05 | Buy | Nov 5, 20 | Filing → |
| Katherine M. ClarkHouse · MA05 | Sell | Oct 22, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Invesco Ltd. | 24.65M | ▲ 15.03M |
| Blackrock, Inc. | 13.80M | ▼ 204.85K |
| Vanguard Group Inc | 10.93M | ▼ 34.73K |
| Goldman Sachs Group Inc | 6.71M | ▼ 677.31K |
| Vanguard Capital Management LLC | 6.06M | ▼ 234.51K |
| Boston Partners | 6.03M | ▲ 303.85K |
| Massachusetts Financial Services Co | 5.15M | ▲ 509.71K |
| Truist Financial Corp | 4.89M | ▲ 140.26K |
| State Street Corp | 4.39M | ▼ 112.98K |
| Norges Bank | 4.00M | ▲ 4.00M |
| Fil Ltd | 3.55M | ▼ 288.54K |
| Morgan Stanley | 3.55M | ▼ 98.80K |
Held by 197 ETFs
Biggest fund positions in CCEP by dollar value.
Our CCEP coverage
Recent articles, reports, and earnings notes.

Coca-Cola Europacific Partners (CCEP): Defensive Growth at a Premium
CCEP combines steady revenue growth, strong cash generation, and shareholder returns with a premium valuation and manageable but not pristine leverage. The report favors a Buy, but notes the stock already prices in much of the near-term good news.

Coca-Cola Europacific Partners (CCEP): A Quality Compounder
CCEP delivered record 2025 revenue, margin expansion, and strong free cash flow, reinforcing its case as a steady compounder. The main debate is valuation, not business quality, with buybacks and dividends supporting returns.

Coca-Cola Europacific Partners PLC (CCEP) climbs 11% after hours
Coca-Cola Europacific Partners PLC (CCEP) climbs more than 11% in after-hours trading, moving back near its 52-week high. The rally appears tied to strong fundamentals, supportive 2026 guidance, and a €1B buyback rather than a fresh company-specific headline.
Want a deeper read on CCEP?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
This Dividend Stock Yielding More Than 4x the Nasdaq-100 Looks Like a Buy Right Now
fool.com · Sep 29
CCEP DCF Analysis: Intrinsic Value $81 vs Price $103
gurufocus.com · Sep 16
Coca-Cola Europacific Partners (NASDAQ:CCEP) Receives Average Recommendation of “Moderate Buy” from Analysts
defenseworld.net · Aug 31
Is CCEP Overvalued? DCF Says Worth $81
gurufocus.com · Aug 26
PRMB or CCEP: Which Is the Better Value Stock Right Now?
zacks.com · Aug 12
Coca-Cola Europacific Partners Q2 Earnings Call Highlights
defenseworld.net · Aug 6
Coca-Cola Europacific Partners PLC (CCEP) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 4
Coca-Cola Europacific Partners Q2 Earnings Call Highlights
marketbeat.com · Aug 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed September 29, 2026 · Live quote · Not investment advice